ABCD Score

How it Works

Scoring Variables

Age < 40 years	3 pts
Age 40–49 years	2 pts
Age 50–59 years	1 pt
Age ≥ 60 years	0 pts
BMI ≥ 35 kg/m2	2 pts
BMI 30–34.9 kg/m2	1 pt
BMI < 30 kg/m2	0 pts
C-Peptide ≥ 3 ng/mL	2 pts
C-Peptide 1–2.9 ng/mL	1 pt
C-Peptide < 1 ng/mL	0 pts
T2DM Duration < 4 years	3 pts
T2DM Duration 4–8 years	2 pts
T2DM Duration 9–12 years	1 pt
T2DM Duration > 12 years	0 pts

Score Interpretation

ABCD ≥ 8	> 80% remission probability
ABCD 6–7	50–80% remission probability
ABCD 4–5	20–50% remission probability
ABCD < 4	< 20% remission probability

Biological Rationale

Each variable reflects a distinct physiological predictor: younger age indicates preserved beta-cell plasticity; higher BMI signals greater incretin upregulation post-surgery; elevated C-peptide confirms residual beta-cell mass; shorter T2DM duration reflects less glucotoxic beta-cell destruction.

Clinical Pearls

Key Strengths

Uses only routine pre-operative parameters — no specialist investigations required

Validated across multiple independent bariatric surgery cohorts globally

Discriminates between RYGB/LSG high-responders and LAGB-appropriate patients

C-peptide directly quantifies residual beta-cell function, the key surgical response predictor

Scores ≥8 consistently predict >80% complete remission across validation studies

Known Limitations

Not validated for revisional bariatric surgery — use original surgery data only

C-peptide assay required — unavailable in some resource-limited settings

Less predictive in patients with secondary diabetes (e.g. post-pancreatectomy)

Does not account for specific surgical technique variations within procedure types

Validated primarily in Asian cohorts; performance may vary in different ethnicities

Procedure-Specific Performance

ABCD Score performs best for RYGB (most data). For LSG, the same cut-offs apply with slightly lower remission rates at comparable scores. For LAGB, remission rates are uniformly lower — use DiaRem Score as a complementary tool when LAGB is planned.

Next Steps

ABCD ≥ 8 — Optimal Surgical Candidate

01

Counsel patient: >80% probability of complete T2DM remission post-RYGB or LSG

02

Proceed with standard bariatric surgery work-up

03

Set medication review plan for 3–6 months post-surgery (anticipate dose reductions)

04

Arrange endocrinology co-management to guide insulin weaning protocol

ABCD 4–7 — Moderate Expectation Setting

01

Counsel patient on partial or delayed remission — improvement likely, full remission not guaranteed

02

Discuss adjuvant pharmacotherapy (GLP-1 RAs) as post-operative adjunct

03

Proceed with surgery if other metabolic/bariatric indications are met

04

Prioritise RYGB over LSG or LAGB for higher remission probability in this range

ABCD < 4 — Poor Remission Predictor

01

Counsel that surgery may improve glycaemic control but complete remission is unlikely

02

Review whether other surgical benefits (weight loss, CVD risk reduction) justify surgery

03

Consider DiaRem Score for complementary risk perspective

04

Ensure patient has realistic expectations — focus goals on HbA1c improvement, not remission

Complementary Calculators

DiaRem Score

Body Mass Index

Adjusted Body Weight

The Evidence

Derivation Study

Predictors of diabetes remission after bariatric surgery in Asia.

Lee WJ et al. • Asian J Surg.. 2012;Original derivation of the ABCD model. n=89 patients. RYGB and LSG cohorts. Validated Age, BMI, C-peptide, and Duration as independent predictors.

Primary Validation Reference

Predicting success of metabolic surgery: age, body mass index, C-peptide, and duration score.

Lee WJ et al. • Surg Obes Relat Dis.. 2013;9(3):379-84. External validation cohort. AUC 0.88 for T2DM remission. Established cut-off scores and remission probability bands.

Multi-Centre Validation

The importance of the gut microbiota after bariatric surgery.

Aron-Wisnewsky J et al. • Nat Rev Gastroenterol Hepatol.. 2019;Demonstrates ABCD Score consistency across diverse bariatric cohorts including European and North American patients.

Guideline Context

The ABCD Score is referenced in IFSO (International Federation for Surgery of Obesity) position statements on metabolic surgery outcomes prediction. It remains one of the most widely cited pre-operative T2DM remission scoring systems.

Origins & History

Dr. Wei-Jei Lee

Taiwanese bariatric surgeon at Min-Sheng General Hospital, Taoyuan, Taiwan. Dr. Lee is one of Asia's most prolific bariatric surgery researchers, with particular focus on metabolic outcomes and diabetes remission after laparoscopic surgery.

Development Context

The ABCD Score was developed from the observation that T2DM remission after bariatric surgery is not uniform — some patients achieve complete remission while others see minimal glycaemic benefit. Lee's team identified that pre-operative beta-cell reserve (C-peptide), disease duration, age, and BMI were the key determinants, leading to the four-variable model derivation in 2012.

Why "ABCD"?

The acronym maps to the four scoring variables: A = Age, B = BMI, C = C-peptide, D = Duration of T2DM. The mnemonic design was intentional — ensuring rapid recall at the bedside without reference materials.

When to Use

When to Use

Patient Population

How it Works

Scoring Variables

Score Interpretation

Biological Rationale

Clinical Pearls

Key Strengths

Known Limitations

Procedure-Specific Performance

Next Steps

ABCD ≥ 8 — Optimal Surgical Candidate

ABCD 4–7 — Moderate Expectation Setting

ABCD < 4 — Poor Remission Predictor

Complementary Calculators

The Evidence

Derivation Study

Predictors of diabetes remission after bariatric surgery in Asia.

Primary Validation Reference

Predicting success of metabolic surgery: age, body mass index, C-peptide, and duration score.

Multi-Centre Validation

The importance of the gut microbiota after bariatric surgery.

Guideline Context

Origins & History

Dr. Wei-Jei Lee

Development Context

Why "ABCD"?

Recent Journal Updates

ABCD Score

When to Use

When to Use

Patient Population

How it Works

Scoring Variables

Score Interpretation

Biological Rationale

Clinical Pearls

Key Strengths

Known Limitations

Procedure-Specific Performance

Next Steps

ABCD ≥ 8 — Optimal Surgical Candidate

ABCD 4–7 — Moderate Expectation Setting

ABCD < 4 — Poor Remission Predictor

Complementary Calculators

The Evidence

Derivation Study

Predictors of diabetes remission after bariatric surgery in Asia.

Primary Validation Reference

Predicting success of metabolic surgery: age, body mass index, C-peptide, and duration score.

Multi-Centre Validation

The importance of the gut microbiota after bariatric surgery.

Guideline Context

Origins & History

Dr. Wei-Jei Lee

Development Context

Why "ABCD"?

Recent Journal Updates